Skip to main content
Elsevier

Journals in Insect biochemistry

  • Current Opinion in Insect Science

    • ISSN: 2214-5745
    Current Opinion in Insect Science is a systematic review journal that provides specialists with a unique and educational platform to keep up to date with the expanding volume of information published in the field of Insect Science. For such a broad discipline, we have determined themed sections, each of which is reviewed once a year.The following 11 defined areas are covered by Current Opinion in Insect Science.MOLECULAR PHYSIOLOGY AND OMICS: Cell physiology, function, communication; immunity, genetics, genomics, proteomics, metabolomics, post-translational processing, epigenetics, physiological genetics, application of new technological approaches, bioinformaticsDEVELO... AND SYSTEMS PHYSIOLOGY: Organism level: Morphogenesis, hormonal regulation, endocrinology, tissue physiology, developmental physiology, interaction between systems to maintain homeostasis, mechanistic physiology from cells to systems, biomechanics ECOLOGY: Behavior and physiology in relation to environment, chemical and physical ecology, population dynamics, population and community ecologyEVOLUTION: Comparative evolutionary morphology, evolutionary physiology and development, evolutionary relationships, natural selection, molecular phylogeny, speciation, behavioral ecologyPESTS AND PEST MANAGEMENT: Major pests of agriculture, invasive species, IPM, resistance and resistance management, biological control, habitat managementMEDICAL, VETERINARY AND URBAN ENTOMOLOGY: Pests of urban, human and / or animal health importance, disease vectors, management SOCIAL INSECTS: Behavior, communication, aspects within or between social insect groupsINSECTS AND THE ANTHROPOCENE: PROBLEMS AND SOLUTIONS: Conservation, biodiversity, invasive species; impacts of climate change, pollution, urbanization, habitat change and management, pesticide regulation, monitoring and surveillanceNEUROSCIENCE: Nervous system physiology, molecular biology of neural systems, developmental biology, toxicology, ethology / neuroethology, brain structure and function, sensory physiologyBIOTECHNOLOGY AND INDUSTRIAL APPLICATIONS: Use of insects or parts thereof for production of useful products, including food and feed; application of bioengineering (microbes, crops, insects) for pest management; new biotechnological approachesSYMBIOSES AND MICROBIAL INTERACTIONS: Interaction of insects with other organisms including plants, pathogens, parasites; microbiome, immunity, vectors of agricultural importanceThere is also a section that changes every year to reflect hot topics in the field.
    Subscriptions

  • Insect Biochemistry and Molecular Biology

    • ISSN: 0965-1748
    This international journal publishes original contributions and mini-reviews in the fields of insect biochemistry and insect molecular biology. Main areas of interest are neurochemistry, hormone and pheromone biochemistry, enzymes and metabolism, hormone action and gene regulation, gene characterization and structure, pharmacology, immunology and cell and tissue culture. Papers on the biochemistry and molecular biology of other groups of arthropods are published if of general interest to the readership. Technique papers will be considered for publication if they significantly advance the field of insect biochemistry and molecular biology in the opinion of the Editors and Editorial Board.Requirements for RNAi Experiments in Lepidopteran Insects1. Use of alternative and complementary methods: Whenever appropriate and feasible, authors are encouraged to consider established genetic approaches such as CRISPR/Cas‑mediated gene knockout prior to relying on RNA interference (RNAi). When RNAi is employed, results should be supported by complementary approaches, including pharmacological inhibition or other independent validation methods.2. Minimization of off‑target effects: To reduce the possibility of off‑target silencing, at least two non‑overlapping dsRNA sequences targeting the same gene must be tested separately.3. Rigorous experimental controls: RNAi experiments must include a non-treatment (or vehicle) control, as well as multiple dsRNA treatment controls (such as dsRNA against unrelated genes like GFP, as well as dsRNA against other endogenous genes, such as those in the same gene family) to demonstrate specificity of the observed phenotypes.4. Demonstration of specific and significant knockdown: Authors must provide quantitative evidence (e.g., qRT‑PCR or other validated quantitative assays) showing that expression of the target gene is significantly reduced by the specific dsRNA treatments, but not by control dsRNAs. A minimum of three independent biological replicates is required for each treatment. Whenever possible, knockdown should also be confirmed by an independent method, such as quantification of the encoded protein.5. Consideration of biological and technical variability: The editorial board recognizes that factors such as dsRNA delivery method, developmental stage, and tissue accessibility can strongly influence RNAi outcomes. Manuscripts will therefore be evaluated on a case‑by‑case basis, taking these experimental constraints into account.
    Subscriptions